Initially, p300 was presumed to behave as a classical tumor suppressor due primarily to its binding to and inactivation by adenovirus E1A (E1A), as well as the discovery of rare truncating mutations in the gene that occur in both primary tumors and cell lines [18]. Here, EP300 is linked to neoplasm.